Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus

被引：0
|
作者：
Shusuke Yagi
Ken-ichi Aihara
Takeshi Kondo
Kiyoe Kurahashi
Sumiko Yoshida
Itsuro Endo
Daiju Fukuda
Yutaka Nakaya
Kin-ichiro Suwaki
Takashi Takeji
Toshihiro Wada
Hotimah Masdan Salim
Saori Hama
Tomomi Matsuura
Takayuki Ise
Kenya Kusunose
Koji Yamaguchi
Takeshi Tobiume
Hirotsugu Yamada
Takeshi Soeki
Tetsuzo Wakatsuki
Munehide Matsuhisa
Michio Shimabukuro
Masashi Akaike
Masataka Sata
机构：
[1] Tokushima University Graduate School of Biomedical Sciences,Department of Cardiovascular Medicine
[2] Tokushima University Graduate School of Biomedical Sciences,Department of Community Medicine and Human Resource Development
[3] Shikoku Central Hospital,Department of Internal Medicine
[4] Tokushima University Graduate School of Biomedical Sciences,Department of Community Medicine for Diabetes and Metabolic Disorders
[5] Tokushima University Graduate School of Biomedical Sciences,Department of Hematology, Endocrinology and Metabolism
[6] Tokushima University Graduate School of Biomedical Sciences,Department of Cardio
[7] Tokushima University,Diabetes Medicine
[8] Fukushima Medical University,Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences
[9] Tokushima University Graduate School of Biomedical Sciences,Department of Diabetes, Endocrinology and Metabolism, School of Medicine
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
Estimated glomerular filtration rate; Glucose-lowering; HbA1c; Predictors; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：124 / 134
页数：10
相关论文
共 50 条
  • [1] Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus
    Yagi, Shusuke
    Aihara, Ken-ichi
    Kondo, Takeshi
    Kurahashi, Kiyoe
    Yoshida, Sumiko
    Endo, Itsuro
    Fukuda, Daiju
    Nakaya, Yutaka
    Suwaki, Kin-ichiro
    Takeji, Takashi
    Wada, Toshihiro
    Salim, Hotimah Masdan
    Hama, Saori
    Matsuura, Tomomi
    Ise, Takayuki
    Kusunose, Kenya
    Yamaguchi, Koji
    Tobiume, Takeshi
    Yamada, Hirotsugu
    Soeki, Takeshi
    Wakatsuki, Tetsuzo
    Matsuhisa, Munehide
    Shimabukuro, Michio
    Akaike, Masashi
    Sata, Masataka
    ADVANCES IN THERAPY, 2018, 35 (01) : 124 - 134
  • [2] Effect of sodium-glucose co-transporter inhibitors on arterial stiffness in patients with type 2 diabetes mellitus
    Szigeti, J.
    Bukva, M.
    Gaszner, B.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [3] The potential role of sodium glucose co-transporter 2 inhibitors in the early treatment of type 2 diabetes mellitus
    Brunton, S. A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (10) : 1071 - 1087
  • [4] Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus
    Rosenthal, Norm
    Meininger, Gary
    Ways, Kirk
    Polidori, David
    Desai, Mehul
    Qiu, Rong
    Alba, Maria
    Vercruysse, Frank
    Balis, Dainius
    Shaw, Wayne
    Edwards, Robert
    Bull, Scott
    Di Prospero, Nicholas
    Sha, Sue
    Rothenberg, Paul
    Canovatchel, William
    Demarest, Keith
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN 2014, 2015, 1358 : 28 - 43
  • [5] Sodium glucose co-transporter 2 inhibitors: A novel approach to the management of type 2 diabetes mellitus
    Davis, Courtney S.
    Fleming, Joshua W.
    Warrington, Laurie E.
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2014, 26 (07) : 356 - 363
  • [6] Emerging sodium/glucose co-transporter 2 inhibitors for type 2 diabetes
    Boyle, Luke D.
    Wilding, John P. H.
    EXPERT OPINION ON EMERGING DRUGS, 2013, 18 (03) : 375 - 391
  • [7] The Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Treatment of Type 2 Diabetes
    Whalen, Karen
    Miller, Shannon
    St Onge, Erin
    CLINICAL THERAPEUTICS, 2015, 37 (06) : 1150 - 1166
  • [8] Benefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
    Jeon, Ja Young
    Kim, Dae Jung
    DIABETES & METABOLISM JOURNAL, 2024, 48 (05) : 837 - 846
  • [9] Place of sodium-glucose co-transporter type 2 inhibitors for treatment of type 2 diabetes
    Mikhail, Nasser
    WORLD JOURNAL OF DIABETES, 2014, 5 (06): : 854 - 859
  • [10] The potential role of sodium glucose co-transporter 2 inhibitors in combination therapy for type 2 diabetes mellitus
    Lajara, Rosemarie
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (17) : 2565 - 2585
12345